Matrix metalloproteinase-2 and matrix metalloproteinase-9 expression in canine and feline meningioma

Veterinary Pathology

Volumn 46, Issue 5, 2009, Pages 836-845

  Mandara, M T ^a   Pavone, S ^a   Mandrioli, L ^b   Bettini, G ^b   Falzone, C ^c   Baroni, M ^c  

^a UNIVERSITY OF PERUGIA   (Italy)

^b School of Veterinary Medicine   (Italy)

^c Clinica Veterinaria Valdinievole   (Italy)

Author keywords

Biologic behavior; Cats; Dogs; Immunohistochemistry; Matrix metalloproteinases; Meningioma

Indexed keywords

CYCLINE; GELATINASE A; GELATINASE B; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; TELOMERASE; TERT PROTEIN, HUMAN;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; DOG; DOG DISEASE; ENZYMOLOGY; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MENINGIOMA; METABOLISM; PATHOLOGY; STATISTICAL MODEL; SURVIVAL;

ANIMALS; CAT DISEASES; CATS; DOG DISEASES; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LINEAR MODELS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MENINGEAL NEOPLASMS; MENINGIOMA; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTORS, PROGESTERONE; SURVIVAL ANALYSIS; TELOMERASE;

CANIS FAMILIARIS; FELIDAE;

EID: 77149163862     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1354/vp.08-VP-0185-M-FL     Document Type: Article

References (48)

1. Abramovich CM, Prayson RA: Histopathologic features and MIB1 labelling indices in recurrent and non recurrent meningiomas. Arch Pathol Lab 16 Med 123(9): 793-800, 1999
2. Adamo F, Cantile C, Steinberg H: Evaluation of progesterone and estrogen receptor expression in 15 meningiomas of dogs and cats. Am J Vet Res 64(2): 1310-1318, 2003 17
3. Axlund TW, McGlasson ML, Smith AN: Surgery alone or in combination with radiation therapy for treatment of intracranial meningiomas in dogs: 31 18 cases (1989-2002). J Vet Med Assoc 221:1597-1600, 2002
4. Bagley RS: Coma, stupor and behavioral change. In: BSAVA Manual of Canine and Feline Neurology, ed. Platt SR and Olby NJ, 3rd ed., pp. 113-132. BSAVA, Gloucester, UK, 2004 19
5. Barnhart KF, Wojcieszyn J, Storts RW: Immunohistochemical staining patterns of canine meningiomas and correlation with immunophenotypes. Vet 20 Pathol 39:311-321, 2002
6. Das A, Tan WL, Smith DR: Express of extracellular matrix markers in benign meningiomas. Neuropa-21 thology 23:275-281, 2003
7. Dickinson PJ, Sturges BK, Higgins RJ, Roberts BN, Leutenegger CM, Bollen AE, LeCouter RA: Vascular endothelial growth factor mRNA expression and peritumoral edema in canine primary central nervous system tumors. Vet Pathol 45:131-139, 2008 22
8. Gallagher JG, Berg J, Knowles KE, Williams LL, Bronson LT: Prognosis after surgical excision of cerebral meningiomas in cats: 17 cases (1986-1992). J Am Vet Med Assoc 203:1437-1440, 1993
9. Goldman CK, Bharara S, Palmer CA, Vitek J, Tsai JC, Weiss HL, Gillespie GY: Brain edema in 23 meningiomas is associated with increased vascular endothelial growth factor expression. Neurosurgery 40(6): 1269-1277, 1997
10. Gordon LE, Thacher C, Matthiesen DT, Joseph R: 24 Results of craniotomy for the treatment of cerebral meningioma in 42 cats. Vet Surg 23(2): 94-100, 1994
11. Heidner GL, Kornegay JN, Page RL, Dodge RK, Thrall DE: Analysis of survival in a retrospective 25 study of 86 dogs with brain tumors. J Vet Int Med 5:219-226, 1991
12. Hsu DW, Efird JT, Hedley-Whyte ET: Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg 86:113-120, 1997
13. Jaaskelainen J: Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. Surg Neurol 26:461, 1986
14. Kajaselcuk F, Zorludemir S, Gümürdü lü D, Zeren H, Erman T: PCNA and Ki-67 in central nervous system tumors: correlation with the histological type and grade. J Neuro-Oncol 57:115-121, 2002
15. Kalkanis SN, Carroll RS, Zhang J, Zampani AA, Black PM: Correlation of vascular endothelial growth factor messenger RNA expression with peritumoral vasogenic cerebral edema in meningiomas. J Neurosurg 85(6): 1095-1101, 1996
16. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T: Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB1 monoclonal antibody on archival material. Acta Neuropathol 87:47-54, 1994
17. Kleiner DE, Stetler-Stevenson WG: Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 43(Suppl): S42-S51, 1999
18. Koestner A, Bilzer T, Fatzer R, Schulman FY, Summers BA, Van Winkle TJ: World Health Organization: Histological Classification of Tumors of the Nervous System of Domestic Animals, pp. 27-29. Armed Forces Institute of Pathology, Washington, DC, 1999
19. Lana SE, Ogilvie GK, Hansen RA: Identification of metalloproteinases in canine neoplastic tissue. Am J Vet Res 61:111-114, 2000
20. Leibman NF, Lana SE, Hansen RA: Identification of matrix metalloproteinases in canine cutaneous mast cell tumors. J Vet Intern Med 14:583-586, 2000
21. Leppert D, Leib SL, Grygar C, Miller KM, Shaad UB, Hollander GA: Matrix metalloproteinase MMP-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae. Clin Infect Dis 31:80-84, 2000
22. Long S, Argyle DJ, Nixon C, Nicholson I, Botteron C, Olby N, Platt S, Smith K, Rutteman GR, Grinwis GCM, Nasir L: Telomerase reverse transcriptase (TERT) expression and proliferation in canine brain tumors. Neuropathol Appl Neurobiol 32:662-673, 2006
23. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK: World Health Organization Classification of Tumours of the Central Nervous System, 4th ed, pp. 163-172. IARC Press, Lyon, France, 2007
24. Maes L, Lippens E, Kalala JPO, de Ridder L: The hTERT-protein and Ki-67 labelling index in recurrent and non-recurrent meningiomas. Cell Prolif 38:3-12, 2005
25. Mandara MT, Ricci G, Rinaldi L, Sarli G, Vitellozzi G: Immunohistochemical identification and image analysis quantification of oestrogen and progesterone receptors in canine and feline meningioma. J Comp Patho; 127:214-218, 2002
26. Mandrioli L, Panarese S, Cesari A, Mandara MT, Marcato PS, Bettini G: Immunohistochemical expression of h-telomerase riverse transcriptase in canine and feline meningiomas. J Vet Sci 8:111-115, 2007
27. Matrisian LM: The matrix metalloproteinases. Bioessays 14:455-463, 1992
28. McDonnel S, Morgan M, Lynch C: Role of matrix metalloproteinases in normal and disease processes. Biotech Soc Transact 27:734-740, 1999
29. Montolius P, Anor S, Vidal E, Pumarola M: Histological and immunohistochemical study of 30 cases of canine meningiomas. J Comp Pathol 135: 200-207, 2006
30. Nakagawa T, Kubota T, Kubotoa M, Kabuto M, Sato K, Kawano H, Hayakawa T, Okada Y: Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 81:69-77, 1994
31. Nuovo GJ: The foundations of successful RT in situ PCR. Front Biosci 1:c4-c15, 1996
32. Ogura E, Senzaki H, Kiyozuda Y: Expression and localization of matrix metalloproteinases and tissue inhibitors of metalloproteinases as a prognostic factor in advanced colorectal carcinomas. Oncol Rep 4:701-705, 1997
33. Okada M, Miyake K, Matsumoto Y, Kawai N: Matrix metalloproteinase-2 and matrix metalloproteinase-9 expression correlate with the recurrence of intracranial meningiomas. J Neuro-Oncol 66:29-37, 2004
34. Panagopoulos AT, Lancellotti CLP, Veiga JCE, de Aguiar PHP, Colquhoun A: Expression of cell adhesion proteins and proteins related to angiogenesis and fatty acid metabolism in benign, atypical, and anaplastic meningiomas. J Neurooncol 89: 73-87, 2008
35. Papparella S, Restucci B, Maiolino P: Immunohistochemical distribution of type IV collagenases in normal, dyspastic and neoplastic canine mammary gland. J Comp Pathol 117:277-282, 1997
36. Patnaik AK, Kay WJ, Hurvitz AI: Intracranial meningioma: a comparative pathologic study of 28 dogs. Vet Pathol 23:369-371, 1986
37. Peak SH, Kim CY, Kim YY, Park IA, Kim MS, Kim DG, Jung HW: Coorelation of clinical and biological parameters eith peritumoral edema in meningiomas. Neurooncology 60:235-245, 2002
38. Petersen SA, Sturges BK, Dickinson PJ, Pollard RE, Kass PH, Kent M, Vernau KM, LeCouter RA, Higgins RJ: Canine intraspinal meningiomas: imag- ing features, histopathologic classification, and longterm outcome in 34 dogs. J Vet Intern Med 22:946-953, 2008
39. Platt SR, Scase TJ, Adams V, Wieczorek L, Miller J, Adamo F, Long S: Vascular endothelial growth factor expression in canine intracranial meningiomas and association with patient survival. J Vet Intern Med 20:663-668, 2006
40. Provias J, Claffey K, delAguila L, Lau N, Feldkamp M, Guha A: Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema. Neurosurgery 40(5):1016-1026, 1997
41. Rao JS, Steck PA, Mohanam S, Stetler-Stevenson WG, Liotta LA, Sawaya R: Cancer Res 53:2208-2211,1993
42. Rutka JT, Giblin J, Dougherty DV, McCulloch JR, DeArmond SJ, Rosenblum ML: An ultrastructural and immunocytochemical analysis of leptomeningeal and meningioma cultures. J Neuropathol Exp Neurol 45:285-303, 1986
43. Sawaya R, Go Y, Kyritsis A: Elevated levels of Mr92,000 type IV collagenase during tumor growth in vivo. Biochem Biophys Res Commun 251:632-636,1998
44. Snyder JM, Shofer FS, Van Winkle TJ, Massicotte G: Canine intracranial primary neoplasia: 173 cases (1986-2003). J Vet Intern Med 20:669-675, 2006
45. Sturges BK, Dickinson PJ, Bollen AW, Koblik PD, Kass PH, Kortz GD, Vernau KM, Knipe MF, LeCouteur RA, Higgins RJ: Magnetic resonance imaging and histological classification of intracranial meningiomas in 112 dogs. J Vet Intern Med 22:586-595,2008
46. Théon AP, LeCouter RA, Car EA, Griffey SM: Influence of tumor cell proliferation and sexhormone receptors on effectiveness of radiation therapy for dogs with incompletely resected meningiomas. J Am Vet Med Assoc 216:701-707, 2000
47. Troxel MT, Vite CH, Van Winkle TJ, Newton AL, Tiches D, Dagrell-Hort B, Kapatkin AS, Shofer FS, Steinberg SA: Feline intracranial neoplasia: retro- spective review of 160 cases (1985-2001). J Vet Intern Med 17:850-859, 2003
48. Von Randow AJ, Schindler S, Tews DS: Expression of extracellular matrix-degrading proteins in classic, atypical, and anaplastic meningiomas. Pathol Res Pract 202(5): 365-372, 2006